1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Closed System Transfer Devices Market by Closing Mechanism, Type, Technology, Component, End User - Global Forecast to 2024

Closed System Transfer Devices Market by Closing Mechanism, Type, Technology, Component, End User - Global Forecast to 2024

  • February 2019
  • 191 pages
  • ID: 5744695
  • Format: PDF
  • By MarketsandMarkets

Summary

Table of Contents

Search Inside

The global closed system transfer devices Market is projected to grow at a CAGR of 20.3%.
The closed system transfer devices market is projected to reach USD 982 million by 2024 from USD 390 million in 2019, at a CAGR of 20.3%. Factors such as the rising incidence of cancer, an increasing number of oncology drug approvals, increasing use of closed system transfer devices to combat the harmful effects of cytotoxic or antineoplastic drugs, and improving regulatory guidelines regarding the safe handling and use of hazardous drugs are driving the growth of the closed system transfer devices market. However, market growth is mainly restricted by the high cost of implementation of CSTDs and lack of reimbursement as well as lack of compliance with regulatory guidelines in developing countries.

Compartmentalized devices to witness the highest growth during the forecast period.
On the basis of technology, the closed system transfer devices market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices.The compartmentalized devices segment is expected to grow at the highest CAGR during the forecast period.

Compartmentalized devices are priced at a lower cost as compared to diaphragm-based devices.Also, these systems are truly closed in nature, providing maximum safety to healthcare workers and patients.

These factors are driving the adoption of compartmentalized devices in the CSTDs market.

Membrane-to-membrane systems to witness the highest growth during the forecast period.
By type, the closed system transfer devices market is segmented into membrane-to-membrane systems and needleless systems.In 2018, the membrane-to-membrane systems segment accounted for the largest share of the closed system transfer devices market.

The large share and high growth of this segment can be attributed to their ease of operation and the lower risk of contamination associated with double-membrane containment systems.

Hospitals to register the highest CAGR during the forecast period.
On the basis of end users, the market is segmented into hospitals, oncology centers & clinics, and other end users.Hospitals are expected to show significant growth opportunities during the forecast period.

The high growth of this segment is mainly due to the strong financial capabilities of hospitals for purchasing high-priced CSTDs as compared to oncology centers and clinics, large cancer patient pool, and the increasing need to comply with the regulatory guidelines established by the FDA and NIOSH regarding the safety of healthcare providers.

Asia Pacific is projected to witness the highest growth during the forecast period.
Asia Pacific is expected to witness the highest CAGR during the forecast period. The rising incidence of cancer, increasing demand for better healthcare services in developing economies, and increasing focus of international players on emerging markets such as India and China are driving the growth of the closed system transfer devices market in the Asia Pacific.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: C-level (45%), Director Level (35%), and Others (20%)
• By Region: North America (55%), Europe (18%), Asia Pacific (12%), Latin America (10%), and the Middle East & Africa (5%)

Prominent players in the closed system transfer devices market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Equashield LLC. (US), B. Braun Melsungen AG (Germany), Corvida Medical (US), Yukon Medical (US), JMS Co., Ltd. (US), CODAN Medizinische Geräte GmbH & Co KG (Germany), Baxter International, Inc. (US), VICTUS (US), and Caragen Ltd. (Ireland).

Research Coverage:
The report analyzes the market for various closed system transfer devices and their adoption patterns.It aims at estimating the market size and future growth potential of the global closed system transfer devices market and different segments such as type, closing mechanism, component, technology, end user, and region.

The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global closed system transfer devices market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches and approvals in the global closed system transfer devices market
• Market Development: Comprehensive information on the lucrative emerging regions by type, closing mechanism, component, technology, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global closed system transfer devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global closed system transfer devices market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H2 2019

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type I (Von Recklinghausen’s ...

Pigmented Villonodular Synovitis - Pipeline Review, H2 2019

Pigmented Villonodular Synovitis - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Pigmented Villonodular Synovitis - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synovitis - Pipeline Review, H2 2019, provides ...

Oral Mucositis Global Clinical Trials Review, H2, 2019

Oral Mucositis Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019

Oral Mucositis Global Clinical Trials Review, H2, 2019Summaryclinical trial report, “Oral Mucositis Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Oral Mucositis clinical ...


ref:plp2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on